AzTrials
AzTrials

Intubation, IntratrachealNCT04439487

Thyromental Height Test as a New Method for Prediction of Difficult Intubation in Obese Patients

An observational study of Intubation, Intratracheal and Obesity, run by Medical University of Silesia at 2 sites in Poland.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The main objective of this trial is to assess the clinical usefulness of thyromental height test (TMHT) in prediction of difficult intubation in obese patients scheduled for elective surgical procedures. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Anthropometric measurements during routine preoperative visit and Assesment of intubation parameters during induction of general anaesthesia
How many people
300 participants
Where
2 sitesPoland
Study dates
1 Jun 2020to 1 Jun 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Studied population will consist of consecutive obese, adult patients (BMI ≥30 kg/m2) qualified for elective surgical procedures, requiring general anaesthesia, direct laryngoscopy and intubation.

Who may be able to join

  • qualification for elective surgical procedures, requiring general anaesthesia, direct laryngoscopy and intubation
  • consent for participation in the trail
  • age ≥18 years
  • BMI ≥30 kg/m2

Who cannot join

  • BMI ≤30 kg/m2
  • patients overweight due to ascites or tumor
  • emergency procedures
  • visible anatomic abnormalities
  • patients scheduled for awake fibreoptic intubation
  • intubation failure
  • lack of consent for participation in the trail

Trial locations and contacts

2 sites in 1 country.

Poland2 sites
  • Medical University of Gdansk

    Gdansk, Pomeranian Voivodeship, 80-214

  • Samodzielny Publiczny Szpital Kliniczny nr 1

    Zabrze, Silesian Voivodeship, 41-800

Other trials in Poland

About this study

The main objective of this trial is to assess the clinical usefulness of thyromental height test (TMHT) in prediction of difficult intubation in obese patients scheduled for elective surgical procedures. The secondary aim is to evaluate usefulness of other commonly used predictive tests associated with difficult intubation in obese patients.

Read the detailed description

Successful and fast intubation are crucial for the safety of general anaesthesia. Failed intubation and acute hypoxia remain among the major contributing factors of anaesthesia related deaths. Difficult intubation prevalence in literature is very inconsistent and varies between 1.5-20% of cases in general population, to even 50% in obese Thai population.

Obesity remains a challenging problem in perioperative care. It is assumed that the airway access may be restricted due to anatomic changes resulting from excess body weight. There are factors like diagnosed obstructive sleep apnoea or large neck circumference that also relate to occurrence of difficult intubation in obese patients.

There is a number of anthropometric scales and tests used for predicting difficult intubation in obese patients. However, none of them appears to be sensitive and specific enough to effectively predict difficult intubation.

Recently, simple and non-invasive test predicting difficult intubation was introduced-thyromental height test (TMHT). It shows promise as a more effective substitution for frequently cited anthropometric measures. It is based on the height between the anterior border of the thyroid cartilage and the anterior border of the mentum, measured while the patient lies in the supine position with closed mouth.

The main objective of this trial is to assess the clinical usefulness of TMHT in prediction of difficult intubation in obese patients scheduled for elective surgical procedures. The secondary aim is to evaluate usefulness of other commonly used predictive tests associated with difficult intubation in obese patients.

Being tested
Anthropometric measurements during routine preoperative visit, Assesment of intubation parameters during induction of general anaesthesia
Keywords
Difficult Intubation, Obesity, Thyromental Height Test
Medical subject headings
Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Anthropometric measurements during routine preoperative visitDiagnostic test

    During routine preoperative anaesthetic visit and physical examination the following predictive test measurements are obtained by a research team member not involved in the further assessment of laryngoscopy: score in modified Mallampati test, Thyromental height, Sternomental distance, Thyromental distance, Neck circumference, Mouth opening distance

  • Assesment of intubation parameters during induction of general anaesthesiaOther

    During induction of general anaesthesia and intubation research team member not involved in obtaining anthropometric measurements notes Number of intubation attempts, Intubation time, Subjective intubation difficulty, Use of bougie and Need of technique modification.

Study groups in NCT04439487
Study groupRoleWhat they receive
Obese patients requiring general anesthesiaGroup consists of consecutive, adult, obese patients undergoing elective surgical procedures requiring general anaesthesia, direct laryngoscopy and intubation. All patients undergo general anesthesia according to a standardised protocol. They are preoxygenated with 100% oxygen breathed through a face mask for 3-5 minutes. Induction of general anaesthesia is achieved with propofol 1,5-2 mg·kg-1 (of Ideal Body Weight) and 0,1mg fentanyl or sufentanil 10µg. Muscle relaxation is accomplished with rocuronium 0.6 mg ·kg-1 (of Ideal Body Weight). Depth of muscular blockade is monitored using Train of Four (TOF) method. The first laryngoscopy attempt is performed at TOF 0. The patient is placed in an optimal, sniffing or ramped position as appropriate and a #3 or #4 Macintosh blade is used. Successful intubation is confirmed with bilateral auscultation and capnography.
Receives: Diagnostic Test: Anthropometric measurements during routine preoperative visit; Other: Assesment of intubation parameters during induction of general anaesthesia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Score in Cormack-Lehane scale (CL).

    During direct laryngoscopy after the induction of general anesthesia the laryngeal view is graded in Cormack-Lehane Scale by the laryngoscopist. Grade I is assigned when the glottis is fully visible, grade II when the glottis is partially visible, grade III when only the epiglottis is visible and grade IV when neither glottis nor epiglottis is visible.

    Measured: Intraoperatively (an average of 5 minutes)

  2. Thyromental height (TMH). [mm]

    Thyromental height is defined as the height between the anterior border of the thyroid cartilage (on the thyroid notch just between the 2 thyroid laminae) and the anterior border of the mentum (on the mental protuberance of the mandible). It is measured with a depth gauge during routine preoperative anaesthetic visit in supine position and closed mouth.

    Measured: Preoperatively (an average of 24 hours)

Secondary outcomes (10)
  1. Thyromental distance (TMD). [cm]

    Thyromental distance is measured during routine preoperative visit as a height between the anterior border of the thyroid cartilage (on the thyroid notch just between the 2 thyroid laminae) and the anterior border of the mentum (on the mental protuberance of the mandible) with a depth gauge (21460605, Limit, Alingsås, Sweden) in millimetres, with the patient in supine position and closed mouth.

    Measured: Preoperatively (an average of 24 hours)

  2. Sternomental distance (SMD). [cm]

    Sternomental distance is measured during routine preoperative visit between the superior border of the manubrium sterni and the most anterior part of the mental prominence of the mandible with a tape measure (Standard, Hoechstmas, Sulzbach, Germany) as a distance in centimetres, with the patient in supine position, head fully extended, mouth closed.

    Measured: Preoperatively (an average of 24 hours)

  3. Score in modified Mallampati test (MMT).

    The oropharyngeal view is assessed according to modified Mallampati scale in sitting position, mouth maximally opened, tongue protruded, without phonation during routine preoperative anaesthetic visit. Grade I is assigned when the soft palate, uvula, fauces and pillars are fully visible, grade II when the soft palate, major part of uvula and fauces are visible, grade III when soft palate and base of uvula are visible and grade IV when only hard palate is visible.

    Measured: Preoperatively (an average of 24 hours)

  4. Mouth opening (MO). [cm]

    Mouth opening is measured as a distance between the lower and upper incisors with a tape measure (Standard, Hoechstmas, Sulzbach, Germany) in centimetres. Patients are in sitting position with mouth maximally opened, tongue retracted and without phonation.

    Measured: Preoperatively (an average of 24 hours)

  5. Neck circumference (NC). [cm]

    Neck circumference is measured at the level of the cricoid cartilage horizontally with a tape measure (Standard, Hoechstmas, Sulzbach, Germany) as a circumference in centimetres in the sitting position during routine preoperative visit.

    Measured: Preoperatively (an average of 24 hours)

  6. Intubation time. [s]

    Intubation time is defined as a time from direct laryngoscopy commencement to confirmation of endotracheal tube placement and noted during induction of general anaesthesia.

    Measured: Intraoperatively (an average of 5 minutes)

  7. Intubation difficulty.

    Subjective evaluation of intubation difficulty is noted during induction of general anaesthesia. Grade I is defined as an easy intubation, grade II a moderate intubation and grade III as a difficult intubation.

    Measured: Intraoperatively (an average of 5 minutes)

  8. Number of intubation attempts.

    Number of intubation attempts defined as a failed direct laryngoscopy without the use of endotracheal tube or insertion of endotracheal tube beyond the teeth line is noted during induction of general anaesthesia.

    Measured: Intraoperatively (an average of 5 minutes)

  9. Use of bougie.

    Necessity to use bougie during induction of general anaesthesia is noted.

    Measured: Intraoperatively (an average of 5 minutes)

  10. Technique modification.

    Necessity to modify technique of laryngoscopy or intubation is noted.

    Measured: Intraoperatively (an average of 5 minutes)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Jun 2020
  2. Study start1 Jun 2020
  3. Primary completion1 Jun 2021 (estimated)
  4. Study completion1 Jun 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04439487
Sponsor's protocol ID
TMHT-02
Status last verified
Jun 2020
First submitted
4 Jun 2020
Last updated
19 Jun 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Intubation, Intratracheal and Obesity, run by Medical University of Silesia at 2 sites in Poland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Jun 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Poland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Score in Cormack-Lehane scale (CL). (time frame: Intraoperatively (an average of 5 minutes)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Jun 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in